Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.

We investigated the effects of low-dose eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the incidence and growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in rats fed a high-fat (HF) diet. We also examined the effects of these treatments on the fatty acid compo...

Full description

Bibliographic Details
Main Authors: Noguchi, M., Minami, M., Yagasaki, R., Kinoshita, K., Earashi, M., Kitagawa, H., Taniya, T., Miyazaki, I.
Format: Online
Language:English
Published: Nature Publishing Group|1 1997
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063366/
id pubmed-2063366
recordtype oai_dc
spelling pubmed-20633662009-09-10 Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. Noguchi, M. Minami, M. Yagasaki, R. Kinoshita, K. Earashi, M. Kitagawa, H. Taniya, T. Miyazaki, I. Research Article We investigated the effects of low-dose eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the incidence and growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in rats fed a high-fat (HF) diet. We also examined the effects of these treatments on the fatty acid composition of tumour and serum. Tumour incidence was significantly decreased by the administration of low-dose EPA and DHA, whereas their inhibitory effects on tumour growth did not reach significance. Serum arachidonic acid (AA) level was decreased by the administration of low-dose EPA and tended to be decreased by the administration of low-dose DHA, whereas tumour AA levels were not changed. The administration of low-dose EPA and DHA may be useful for inhibiting the incidence of breast cancer. Nature Publishing Group|1 1997 /pmc/articles/PMC2063366/ /pubmed/9020478 Text en
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Noguchi, M.
Minami, M.
Yagasaki, R.
Kinoshita, K.
Earashi, M.
Kitagawa, H.
Taniya, T.
Miyazaki, I.
spellingShingle Noguchi, M.
Minami, M.
Yagasaki, R.
Kinoshita, K.
Earashi, M.
Kitagawa, H.
Taniya, T.
Miyazaki, I.
Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.
author_facet Noguchi, M.
Minami, M.
Yagasaki, R.
Kinoshita, K.
Earashi, M.
Kitagawa, H.
Taniya, T.
Miyazaki, I.
author_sort Noguchi, M.
title Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.
title_short Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.
title_full Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.
title_fullStr Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.
title_full_unstemmed Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.
title_sort chemoprevention of dmba-induced mammary carcinogenesis in rats by low-dose epa and dha.
description We investigated the effects of low-dose eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the incidence and growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in rats fed a high-fat (HF) diet. We also examined the effects of these treatments on the fatty acid composition of tumour and serum. Tumour incidence was significantly decreased by the administration of low-dose EPA and DHA, whereas their inhibitory effects on tumour growth did not reach significance. Serum arachidonic acid (AA) level was decreased by the administration of low-dose EPA and tended to be decreased by the administration of low-dose DHA, whereas tumour AA levels were not changed. The administration of low-dose EPA and DHA may be useful for inhibiting the incidence of breast cancer.
publisher Nature Publishing Group|1
publishDate 1997
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063366/
_version_ 1611406090620108800